Beating cancer by early detection and personalised treatment - with Adam Hill, CEO of Oncimmune plc
16 Jul 2020
Matt Venning, The Impact Interview
"I joined Oncimmune two years ago and very much, joined a company that I felt had a huge amount of potential, a well-protected proprietary platform, some excellent scientists that very much form the brain trust of the organisation, enable to pivot our science into proprietary products."
Dr Adam M Hill